DBP International AB: Manufacturing of the excipient for SI-053 is done
The manufacturing of the excipient for SI-053 has been carried out in a European GMP-certified facility, a contract-based manufacturer within the EU. This product will be used for the manufacturing of SI-053 which is scheduled to start next month and which will be used for DBP's clinical trials. DBP has previously reported on successful technical transfer of the excipient for SI-053 and successful SI-053 manufacturing for CTA with associated stability studies, in European GMP-certified environments, which is the basis for today's successful work. "This is an important success for us,